Zhejiang Benli Technology Co., Ltd.

SZSE:301065 Stock Report

Market Cap: CN¥2.0b

Zhejiang Benli Technology Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Zhejiang Benli Technology.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest

Nov 01
Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest

What Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) 42% Share Price Gain Is Not Telling You

Aug 08
What Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) 42% Share Price Gain Is Not Telling You

Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year

Jun 19
Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year

Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E

Jun 07
Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E

We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings

May 02
We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings

Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%

Mar 08
Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zhejiang Benli Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:301065 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202471262194316N/A
6/30/202473471142239N/A
3/31/20247166491155N/A
12/31/2023698602892N/A
9/30/202368656-1935N/A
6/30/202367749-8830N/A
3/31/202373056-11226N/A
1/1/202375960-8843N/A
9/30/202274061-8022N/A
6/30/202271761546N/A
3/31/2022662552135N/A
1/1/202262155-1436N/A
9/30/202164671-4246N/A
6/30/202165387-3071N/A
3/31/202163387-2193N/A
12/31/202062592898N/A
9/30/202060595N/AN/AN/A
12/31/201955973-4110N/A
12/31/2018438453858N/A
12/31/201733725N/A18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 301065's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 301065's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 301065's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 301065's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 301065's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 301065's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y